STOCK TITAN

[Form 4] The RealReal, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

TheRealReal, Inc. (REAL) – Form 4 insider filing

Director Caretha Coleman reported the grant of 26,025 deferred restricted stock units (DRSUs) on 07/23/2025. Each DRSU converts into one share of REAL common stock upon settlement; the grant carried a stated price of $0, indicating an equity-based compensation award rather than an open-market purchase. Following the award, Coleman's direct beneficial ownership rises to 251,783 shares, further aligning the director’s economic interest with shareholders. No derivative securities were involved and no dispositions were reported.

The filing is routine compensation-related and does not include any earnings data or guidance. While the additional shares modestly increase insider ownership, the absence of cash consideration or open-market buying means the signal for outside investors is limited.

TheRealReal, Inc. (REAL) – Comunicazione interna Form 4

La direttrice Caretha Coleman ha segnalato la concessione di 26.025 unità azionarie vincolate differite (DRSU) in data 23/07/2025. Ogni DRSU si converte in un'azione ordinaria REAL al momento della liquidazione; la concessione ha un prezzo nominale di $0, indicando un premio azionario come compenso piuttosto che un acquisto sul mercato aperto. Dopo l'assegnazione, la posizione diretta di proprietà benefica di Coleman sale a 251.783 azioni, allineando maggiormente gli interessi economici della direttrice con quelli degli azionisti. Non sono stati coinvolti strumenti derivati né sono state segnalate cessioni.

La comunicazione è di routine e riguarda la compensazione, senza includere dati sugli utili o previsioni. Sebbene le azioni aggiuntive aumentino leggermente la partecipazione interna, l'assenza di un corrispettivo in denaro o di acquisti sul mercato aperto limita il segnale per gli investitori esterni.

TheRealReal, Inc. (REAL) – Presentación interna Formulario 4

La directora Caretha Coleman informó la concesión de 26,025 unidades restringidas diferidas (DRSUs) el 23/07/2025. Cada DRSU se convierte en una acción común de REAL al momento del pago; la concesión tuvo un precio declarado de $0, lo que indica una compensación basada en acciones en lugar de una compra en el mercado abierto. Tras la adjudicación, la propiedad directa beneficiaria de Coleman aumenta a 251,783 acciones, alineando aún más el interés económico de la directora con el de los accionistas. No se involucraron valores derivados ni se reportaron disposiciones.

La presentación es rutinaria y relacionada con la compensación, sin incluir datos de ganancias ni pronósticos. Aunque las acciones adicionales aumentan modestamente la propiedad interna, la ausencia de consideración en efectivo o compras en mercado abierto limita la señal para los inversores externos.

TheRealReal, Inc. (REAL) – 내부자 보고서 Form 4

이사 Caretha Coleman은 2025년 7월 23일에 26,025개의 이연 제한 주식 단위(DRSU) 부여를 보고했습니다. 각 DRSU는 결제 시 REAL 보통주 1주로 전환되며, 부여 가격은 $0으로 명시되어 있어 공개 시장에서의 구매가 아닌 주식 기반 보상임을 나타냅니다. 이 보상 이후 Coleman 이사의 직접 실질 소유 주식 수가 251,783주로 증가하여 이사의 경제적 이익이 주주들과 더욱 일치하게 되었습니다. 파생 증권은 포함되지 않았으며 처분 보고도 없었습니다.

해당 보고는 보상 관련 일상적 신고로, 수익 데이터나 지침은 포함하지 않습니다. 추가 주식으로 내부자 소유가 소폭 증가했지만 현금 대가나 공개 시장 매수가 없으므로 외부 투자자에게 주는 신호는 제한적입니다.

TheRealReal, Inc. (REAL) – Déclaration d’initié Formulaire 4

La directrice Caretha Coleman a déclaré la cession de 26 025 unités d’actions restreintes différées (DRSUs) le 23/07/2025. Chaque DRSU se convertit en une action ordinaire REAL lors du règlement ; la cession était à un prix déclaré de 0 $, indiquant une rémunération en actions plutôt qu’un achat sur le marché libre. Suite à cette attribution, la possession directe bénéficiaire de Coleman atteint 251 783 actions, alignant davantage les intérêts économiques de la directrice avec ceux des actionnaires. Aucun titre dérivé n’a été impliqué et aucune cession n’a été rapportée.

La déclaration est une formalité liée à la rémunération et ne comprend aucune donnée sur les bénéfices ni prévisions. Bien que les actions supplémentaires augmentent modestement la détention interne, l’absence de contrepartie en espèces ou d’achat sur le marché libre limite le signal envoyé aux investisseurs externes.

TheRealReal, Inc. (REAL) – Insider-Meldung Form 4

Direktorin Caretha Coleman meldete am 23.07.2025 die Gewährung von 26.025 aufgeschobenen Restricted Stock Units (DRSUs). Jede DRSU wandelt sich bei Ausgleich in eine Aktie der REAL-Stammaktien um; die Gewährung hatte einen angegebenen Preis von 0 $, was auf eine aktienbasierte Vergütung statt eines Kaufs am freien Markt hinweist. Nach der Zuteilung steigt Colemans direkter wirtschaftlicher Eigentumsanteil auf 251.783 Aktien und bringt so die wirtschaftlichen Interessen der Direktorin stärker mit denen der Aktionäre in Einklang. Es waren keine Derivate beteiligt und keine Veräußerungen wurden gemeldet.

Die Meldung ist routinemäßig und vergütungsbezogen, enthält jedoch keine Gewinnzahlen oder Prognosen. Obwohl die zusätzlichen Aktien den Insiderbesitz leicht erhöhen, ist das Signal für externe Investoren aufgrund des Fehlens von Barzahlung oder Käufen am offenen Markt begrenzt.

Positive
  • Director’s ownership increases by 26,025 shares, slightly enhancing board-shareholder alignment.
Negative
  • Grant is compensation-based at $0 cost, so it provides limited insight into the director’s market conviction or REAL’s valuation.

Insights

TL;DR: Routine equity grant; modestly raises insider stake, neutral fundamental impact.

The award adds ~26k shares to a director’s holdings, lifting total ownership to roughly 0.25 million shares. Because the shares stem from deferred RSUs issued at no cost, the transaction reflects standard board compensation, not a discretionary purchase that might indicate management’s valuation view. Consequently, the filing offers little insight into REAL’s near-term performance or valuation trajectory. Market impact should be minimal, though incremental alignment with shareholders can be viewed as a small positive for governance.

TL;DR: Governance-neutral event; standard board compensation structure.

Deferred RSU grants are customary for non-employee directors among NASDAQ-listed firms. The settlement feature defers tax liability and fosters longer-term ownership. Coleman's increased stake marginally strengthens board-shareholder alignment but does not alter control dynamics. No red flags or unusual structures appear; thus, the event is governance-neutral and not expected to influence investor sentiment.

TheRealReal, Inc. (REAL) – Comunicazione interna Form 4

La direttrice Caretha Coleman ha segnalato la concessione di 26.025 unità azionarie vincolate differite (DRSU) in data 23/07/2025. Ogni DRSU si converte in un'azione ordinaria REAL al momento della liquidazione; la concessione ha un prezzo nominale di $0, indicando un premio azionario come compenso piuttosto che un acquisto sul mercato aperto. Dopo l'assegnazione, la posizione diretta di proprietà benefica di Coleman sale a 251.783 azioni, allineando maggiormente gli interessi economici della direttrice con quelli degli azionisti. Non sono stati coinvolti strumenti derivati né sono state segnalate cessioni.

La comunicazione è di routine e riguarda la compensazione, senza includere dati sugli utili o previsioni. Sebbene le azioni aggiuntive aumentino leggermente la partecipazione interna, l'assenza di un corrispettivo in denaro o di acquisti sul mercato aperto limita il segnale per gli investitori esterni.

TheRealReal, Inc. (REAL) – Presentación interna Formulario 4

La directora Caretha Coleman informó la concesión de 26,025 unidades restringidas diferidas (DRSUs) el 23/07/2025. Cada DRSU se convierte en una acción común de REAL al momento del pago; la concesión tuvo un precio declarado de $0, lo que indica una compensación basada en acciones en lugar de una compra en el mercado abierto. Tras la adjudicación, la propiedad directa beneficiaria de Coleman aumenta a 251,783 acciones, alineando aún más el interés económico de la directora con el de los accionistas. No se involucraron valores derivados ni se reportaron disposiciones.

La presentación es rutinaria y relacionada con la compensación, sin incluir datos de ganancias ni pronósticos. Aunque las acciones adicionales aumentan modestamente la propiedad interna, la ausencia de consideración en efectivo o compras en mercado abierto limita la señal para los inversores externos.

TheRealReal, Inc. (REAL) – 내부자 보고서 Form 4

이사 Caretha Coleman은 2025년 7월 23일에 26,025개의 이연 제한 주식 단위(DRSU) 부여를 보고했습니다. 각 DRSU는 결제 시 REAL 보통주 1주로 전환되며, 부여 가격은 $0으로 명시되어 있어 공개 시장에서의 구매가 아닌 주식 기반 보상임을 나타냅니다. 이 보상 이후 Coleman 이사의 직접 실질 소유 주식 수가 251,783주로 증가하여 이사의 경제적 이익이 주주들과 더욱 일치하게 되었습니다. 파생 증권은 포함되지 않았으며 처분 보고도 없었습니다.

해당 보고는 보상 관련 일상적 신고로, 수익 데이터나 지침은 포함하지 않습니다. 추가 주식으로 내부자 소유가 소폭 증가했지만 현금 대가나 공개 시장 매수가 없으므로 외부 투자자에게 주는 신호는 제한적입니다.

TheRealReal, Inc. (REAL) – Déclaration d’initié Formulaire 4

La directrice Caretha Coleman a déclaré la cession de 26 025 unités d’actions restreintes différées (DRSUs) le 23/07/2025. Chaque DRSU se convertit en une action ordinaire REAL lors du règlement ; la cession était à un prix déclaré de 0 $, indiquant une rémunération en actions plutôt qu’un achat sur le marché libre. Suite à cette attribution, la possession directe bénéficiaire de Coleman atteint 251 783 actions, alignant davantage les intérêts économiques de la directrice avec ceux des actionnaires. Aucun titre dérivé n’a été impliqué et aucune cession n’a été rapportée.

La déclaration est une formalité liée à la rémunération et ne comprend aucune donnée sur les bénéfices ni prévisions. Bien que les actions supplémentaires augmentent modestement la détention interne, l’absence de contrepartie en espèces ou d’achat sur le marché libre limite le signal envoyé aux investisseurs externes.

TheRealReal, Inc. (REAL) – Insider-Meldung Form 4

Direktorin Caretha Coleman meldete am 23.07.2025 die Gewährung von 26.025 aufgeschobenen Restricted Stock Units (DRSUs). Jede DRSU wandelt sich bei Ausgleich in eine Aktie der REAL-Stammaktien um; die Gewährung hatte einen angegebenen Preis von 0 $, was auf eine aktienbasierte Vergütung statt eines Kaufs am freien Markt hinweist. Nach der Zuteilung steigt Colemans direkter wirtschaftlicher Eigentumsanteil auf 251.783 Aktien und bringt so die wirtschaftlichen Interessen der Direktorin stärker mit denen der Aktionäre in Einklang. Es waren keine Derivate beteiligt und keine Veräußerungen wurden gemeldet.

Die Meldung ist routinemäßig und vergütungsbezogen, enthält jedoch keine Gewinnzahlen oder Prognosen. Obwohl die zusätzlichen Aktien den Insiderbesitz leicht erhöhen, ist das Signal für externe Investoren aufgrund des Fehlens von Barzahlung oder Käufen am offenen Markt begrenzt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Coleman Caretha

(Last) (First) (Middle)
C/O THEREALREAL, INC.
55 FRANCISCO STREET 4TH FLOOR

(Street)
SAN FRANCISCO CA 94133

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TheRealReal, Inc. [ REAL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/23/2025 A 26,025(1) A $0 251,783 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.
Remarks:
by Todd Suko, Attorney in Fact for Caretha Coleman 07/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did Director Caretha Coleman acquire in the latest REAL Form 4?

The filing shows an acquisition of 26,025 deferred restricted stock units equivalent to 26,025 common shares.

What is Coleman's total beneficial ownership in TheRealReal (REAL) after the transaction?

After the grant, Coleman directly owns 251,783 shares of REAL common stock.

Was the acquisition an open-market purchase or a stock grant?

It was a stock grant of deferred restricted stock units with a stated price of $0, not an open-market purchase.

Does the Form 4 contain any dispositions or sales of REAL shares?

No. No shares were sold; the filing reports only an acquisition via RSUs.

Is the filing likely to affect TheRealReal’s stock price?

Because the shares are part of routine director compensation, the filing is unlikely to materially impact REAL’s share price.
Therealreal

NASDAQ:REAL

REAL Rankings

REAL Latest News

REAL Latest SEC Filings

REAL Stock Data

722.68M
96.74M
12.7%
77.07%
15.07%
Luxury Goods
Retail-miscellaneous Retail
Link
United States
SAN FRANCISCO